EdgarLookup

Taysha Gene Therapies, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Financials Insiders
Insider Title Type Shares Price Value Date
Nagendran Sukumar President and Head of R&D Option Exercise 260,047 $1.71 $444,680 Nov 28, 2025
Nagendran Sukumar President and Head of R&D Sale 200,000 $3.23 $646,000 Sep 10, 2025
Nagendran Sukumar President and Head of R&D Sale 57,054 $2.85 $162,604 Aug 21, 2025
Alam Kamran CHIEF FINANCIAL OFFICER Sale 54,491 $2.85 $155,299 Aug 21, 2025
Stalfort John A III Award / Grant 56,623 Jun 2, 2025
Donenberg Phillip B. Award / Grant 56,623 Jun 2, 2025
Long Alison S Award / Grant 56,623 Jun 2, 2025
Sepp-Lorenzino Laura Award / Grant 56,623 Jun 2, 2025
Manning Paul B Purchase 750,000 $2.75 $2,062,500 May 30, 2025
Alam Kamran CHIEF FINANCIAL OFFICER Tax Withholding 29,843 $1.69 $50,435 Mar 11, 2025
Nolan Sean P. Chief Executive Officer Award / Grant 892,500 Jan 2, 2025
Nagendran Sukumar President and Head of R&D Award / Grant 324,500 Jan 2, 2025
Alam Kamran CHIEF FINANCIAL OFFICER Award / Grant 431,000 Jan 2, 2025
Manning Paul B Purchase 1,333,333 $2.25 $2,999,999 Jun 27, 2024
Stalfort John A III Award / Grant 49,220 May 29, 2024
Long Alison S Award / Grant 49,220 May 29, 2024
Donenberg Phillip B. Award / Grant 49,220 May 29, 2024
Sepp-Lorenzino Laura Award / Grant 49,220 May 29, 2024
Alam Kamran CHIEF FINANCIAL OFFICER Tax Withholding 1,288 $1.51 $1,945 Feb 2, 2024
Alam Kamran Chief Financial Officer Award / Grant 590,413 Jan 2, 2024
Nagendran Sukumar President and Head of R&D Award / Grant 863,617 Jan 2, 2024
Nolan Sean P. Chief Executive Officer Award / Grant 1,184,688 Jan 2, 2024
Manning Paul B Purchase 100,000 $1.63 $163,000 Nov 17, 2023
Alam Kamran Chief Financial Officer Sale 33,000 $2.33 $76,890 Aug 24, 2023
Manning Paul B Purchase 16,466,667 $0.90 $14,820,000 Aug 16, 2023
Stalfort John A III Gift 50,000 Aug 16, 2023
Nolan Sean P. Chief Executive Officer Purchase 444,444 $0.90 $400,000 Aug 16, 2023
Donenberg Phillip B. Purchase 111,111 $0.90 $100,000 Aug 16, 2023
Session R.A. II Sale 80,528 $0.71 $57,175 Jul 13, 2023
Session R.A. II Sale 10,508 $0.70 $7,356 Jun 23, 2023
Session R.A. II Sale 295,653 $0.71 $209,914 Jun 21, 2023
Alam Kamran Chief Financial Officer Award / Grant 6,230 May 31, 2023
Nagendran Sukumar President and Head of R&D Purchase 5,000 $0.68 $3,400 May 16, 2023
Session R.A. II Other 251,296 Mar 6, 2023
Alam Kamran Chief Financial Officer Award / Grant 18,691 Feb 2, 2023
Manning Paul B Purchase 1,500,000 $2.00 $3,000,000 Oct 31, 2022
Alam Kamran Chief Financial Officer Sale 3,325 $3.47 $11,538 Aug 23, 2022
Alam Kamran Chief Financial Officer Sale 9,717 $3.50 $34,010 Aug 18, 2022
PRASAD SUYASH CMO and Head of R&D Sale 8,956 $3.79 $33,943 Jul 5, 2022
PRASAD SUYASH CMO and Head of R&D Sale 12,324 $3.81 $46,954 Jun 30, 2022
Manning Paul B Purchase 45,000 $7.77 $349,650 Feb 3, 2022
Donenberg Phillip B. Purchase 3,000 $7.78 $23,340 Feb 2, 2022
Nagendran Sukumar Purchase 10,000 $8.01 $80,100 Feb 2, 2022
Manning Paul B Purchase 2,202 $13.19 $29,044 Nov 24, 2021
Session R.A. II President and CEO Purchase 26,008 $12.65 $329,001 Nov 23, 2021
Manning Paul B Purchase 20,000 $12.54 $250,800 Nov 23, 2021
Alam Kamran Chief Financial Officer Sale 613 $17.11 $10,488 Aug 18, 2021
PRASAD SUYASH CMO and Head of R&D Sale 300 $25.19 $7,557 Jun 29, 2021
Nolan Sean P. Purchase 1,170 $22.35 $26,150 May 20, 2021
Manning Paul B Purchase 12,000 $20.98 $251,760 May 14, 2021